What we offer?
Centrum HTA is engaged in consulting services related to the pharmaceutical market in Poland. The company’s activity covers a broad spectrum of services concerning: Health Technology Analyses production for pharmaceuticals and medical products as well as pharmaceutical market review in Poland.
FULL HTA DOSSIER
- Decision Problem Analysis
- Clinical analysis
- Economic analysis
- Budget Impact Analysis
- Rationalization Analysis
CHARACTERISTICS OF THE PHARMACEUTICAL MARKET IN POLAND
REVIEW OF EPIDEMIOLOGICAL AND COST SPECIFIC DATA IN POLISH SETTINGS
SYSTEMATIC REVIEW OF CLINICAL TRIALS
BUDGET IMPACT ANALYSIS FOR GENERIC DRUGS
FULL TEXT PUBLICATIONS
WORKSHOPS
ON EBM AND HTA
ADVISORY BOARDS
SCIENTIFIC CONFERENCES MATERIALS
FULL RANGE REIMBURSEMENT CONSULTING
HTA ANALYZES ARE DEVELOPED BY THE TEAM OF CENTRUM HTA WITH GREAT ACCURACY ACCORDING TO THE FOLLOWING REQUIREMENTS
Act of May 12, 2011 on reimbursement of medicines, foodstuffs for particular nutritional purposes and medical devices (as amended)
Minimum requirements to be satisfied by the analysis contained in reimbursement application. The English version of Regulation of the Minister Of Health of 8 January 2021 on the minimum requirements to be satisfied by the analyses accounted for in the applications for reimbursement and setting the official sales price and for increasing the official sales price of a drug, a special purpose dietary supplement, a medical device, which do not have a reimbursed counterpart in a given indication
Health Technology Assessment Guidelines Version 3.0 Warsaw, August 2016 (publication date 14 of September 2016)